After receiving his BS and MS from Nanjing University, Bing Xu obtained his PhD in 1996 from the University of Pennsylvania under the supervision of Timothy Swager. Before starting his independent research at the Hong Kong University of Science and Technology on the Aug. 2000, he was an NIH postdoctoral fellow with George Whitesides at Harvard University. Notably, Xu lab has made pioneering contributions in several research areas, including the integration of enzyme and self-assembly for developing responsive biomaterials, synthesized the first dimeric nanoparticle consisting of quantum dot and nanomagnet for exploring nanoscience inside cells, reported the first case of using dopamine to anchor molecules on iron oxide surface, coined the term of "metallogel" and demonstrated the first use of metallogels for catalysis. and demonstrated the first case of using enzymatic transformation and self-assembly to inhibit cancer cells selectively. Bing Xu was tenured as an associated professor in Jan 2006, became a full professor in July 2008 at HKUST, then moved to Brandeis Unversity in fall of 2008. Based on his works in HKUST and Brandeis, Bing Xu was identified by as "Highly-Cited Researchers in Chemistry" for 2014, 2015, 2016, and 2017. His currently is a professor in the Department of Chemistry, Brandeis University. His research focuses on the applications of molecular engineering in chemistry, materials science, biology, and medicine.